Partnerships
Lab21 is a leading provider of diagnostic products and laboratory developed tests

Lab21 is Your Diagnostic Partner for development and commercialisation of molecular and immunodiagnostics, with special expertise in Oncology and Infectious Diseases.

We provide:
  • Comprehensive Companion Diagnostics solutions
  • Biomarker assay development services, including nucleic acid and protein based, for most platforms available in the market today
  • Manufacture, regulatory approval and distribution of biomarker assays
  • Proprietary position with unique SPARQ™ PCR and Selah Dot™ photoluminescent nanoparticle technologies
Lab21 is a vertically integrated diagnostics company with comprehensive, fully accredited Diagnostic Products and Clinical Laboratory service capabilities. We are platform agnostic and able to develop products and services for any molecular or immunodiagnostic platform required by our Partners.

Lab21 services include biomarker assay development & validation, clinical trial services, manufacture and assay commercialisation & distribution. We can also advise on the best strategy for your biomarker.

Please click on the links below or on the right for more information.